Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (2196.HK)
HKD 14.64
(0.69%)
HKD 14.64
(0.69%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 2.38 Billion CNY | -36.04% |
| 2022 | 3.73 Billion CNY | -21.1% |
| 2021 | 4.72 Billion CNY | 29.1% |
| 2020 | 3.66 Billion CNY | 10.27% |
| 2019 | 3.32 Billion CNY | 22.66% |
| 2018 | 2.7 Billion CNY | -13.33% |
| 2017 | 3.12 Billion CNY | 11.36% |
| 2016 | 2.8 Billion CNY | 14.05% |
| 2015 | 2.46 Billion CNY | 16.43% |
| 2014 | 2.11 Billion CNY | 4.23% |
| 2013 | 2.02 Billion CNY | 29.61% |
| 2012 | 1.56 Billion CNY | 34.17% |
| 2011 | 1.16 Billion CNY | 34.96% |
| 2010 | 863.65 Million CNY | -65.43% |
| 2009 | 2.49 Billion CNY | 261.61% |
| 2008 | 690.85 Million CNY | 10.4% |
| 2007 | 625.78 Million CNY | 141.47% |
| 2006 | 259.15 Million CNY | 62.96% |
| 2005 | 159.03 Million CNY | -26.15% |
| 2004 | 215.33 Million CNY | -18.32% |
| 2003 | 263.61 Million CNY | 79.08% |
| 2002 | 147.21 Million CNY | 8.63% |
| 2001 | 135.51 Million CNY | 5.45% |
| 2000 | 128.51 Million CNY | 39.45% |
| 1999 | 92.15 Million CNY | 44.61% |
| 1998 | 63.72 Million CNY | 76.89% |
| 1997 | 36.02 Million CNY | 464.89% |
| 1996 | 6.37 Million CNY | 6.69% |
| 1995 | 5.97 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 615.06 Million CNY | 0.87% |
| 2024 Q3 | 785.84 Million CNY | 27.77% |
| 2024 Q1 | 609.73 Million CNY | 490.83% |
| 2023 FY | 2.38 Billion CNY | -36.04% |
| 2023 Q1 | 986.97 Million CNY | -22.68% |
| 2023 Q2 | 790.5 Million CNY | -19.91% |
| 2023 Q3 | 505.59 Million CNY | -36.04% |
| 2023 Q4 | 103.19 Million CNY | -79.59% |
| 2022 Q4 | 1.27 Billion CNY | 40.73% |
| 2022 Q1 | 644.28 Million CNY | -44.96% |
| 2022 Q2 | 1.08 Billion CNY | 68.38% |
| 2022 Q3 | 907.03 Million CNY | -16.39% |
| 2022 FY | 3.73 Billion CNY | -21.1% |
| 2021 Q1 | 847.18 Million CNY | -28.44% |
| 2021 Q2 | 1.63 Billion CNY | 93.01% |
| 2021 Q3 | 1.08 Billion CNY | -33.81% |
| 2021 Q4 | 1.17 Billion CNY | 8.15% |
| 2021 FY | 4.72 Billion CNY | 29.1% |
| 2020 Q3 | 764.27 Million CNY | -32.81% |
| 2020 Q2 | 1.13 Billion CNY | 97.07% |
| 2020 Q4 | 1.18 Billion CNY | 54.9% |
| 2020 Q1 | 577.19 Million CNY | -54.11% |
| 2020 FY | 3.66 Billion CNY | 10.27% |
| 2019 FY | 3.32 Billion CNY | 22.66% |
| 2019 Q3 | 547.58 Million CNY | -31.88% |
| 2019 Q2 | 803.82 Million CNY | 12.85% |
| 2019 Q4 | 1.25 Billion CNY | 129.72% |
| 2019 Q1 | 712.29 Million CNY | 16.05% |
| 2018 Q2 | 854.68 Million CNY | 21.1% |
| 2018 Q4 | 613.77 Million CNY | 15.01% |
| 2018 FY | 2.7 Billion CNY | -13.33% |
| 2018 Q1 | 705.78 Million CNY | 0.08% |
| 2018 Q3 | 533.68 Million CNY | -37.56% |
| 2017 Q4 | 705.23 Million CNY | -3.42% |
| 2017 Q3 | 730.2 Million CNY | -23.24% |
| 2017 Q1 | 737.74 Million CNY | 17.3% |
| 2017 FY | 3.12 Billion CNY | 11.36% |
| 2017 Q2 | 951.31 Million CNY | 28.95% |
| 2016 Q2 | 866.03 Million CNY | 36.55% |
| 2016 FY | 2.8 Billion CNY | 14.05% |
| 2016 Q4 | 628.94 Million CNY | -7.05% |
| 2016 Q3 | 676.62 Million CNY | -21.87% |
| 2016 Q1 | 634.23 Million CNY | 11.44% |
| 2015 FY | 2.46 Billion CNY | 16.43% |
| 2015 Q4 | 569.12 Million CNY | -3.13% |
| 2015 Q3 | 587.48 Million CNY | -23.42% |
| 2015 Q2 | 767.12 Million CNY | 43.03% |
| 2015 Q1 | 536.35 Million CNY | -0.36% |
| 2014 FY | 2.11 Billion CNY | 4.23% |
| 2014 Q4 | 538.28 Million CNY | -3.36% |
| 2014 Q3 | 557.02 Million CNY | -5.28% |
| 2014 Q2 | 588.09 Million CNY | 42.08% |
| 2014 Q1 | 413.91 Million CNY | -35.12% |
| 2013 Q2 | 701.13 Million CNY | 99.18% |
| 2013 FY | 2.02 Billion CNY | 29.61% |
| 2013 Q1 | 352 Million CNY | -25.22% |
| 2013 Q3 | 335.93 Million CNY | -52.09% |
| 2013 Q4 | 637.97 Million CNY | 89.91% |
| 2012 Q1 | 335.22 Million CNY | 241.85% |
| 2012 Q2 | 366.54 Million CNY | 9.34% |
| 2012 Q4 | 470.69 Million CNY | 20.24% |
| 2012 FY | 1.56 Billion CNY | 34.17% |
| 2012 Q3 | 391.45 Million CNY | 6.8% |
| 2011 Q3 | 200.84 Million CNY | -67.3% |
| 2011 Q1 | 252.47 Million CNY | 100.95% |
| 2011 Q2 | 614.22 Million CNY | 143.28% |
| 2011 FY | 1.16 Billion CNY | 34.96% |
| 2011 Q4 | 98.06 Million CNY | -51.18% |
| 2010 FY | 863.65 Million CNY | -65.43% |
| 2010 Q1 | 330.33 Million CNY | 17.55% |
| 2010 Q3 | 186.57 Million CNY | -15.62% |
| 2010 Q2 | 221.1 Million CNY | -33.06% |
| 2010 Q4 | 125.64 Million CNY | -32.66% |
| 2009 Q2 | 170.35 Million CNY | -1.35% |
| 2009 Q4 | 281.02 Million CNY | -85.01% |
| 2009 Q3 | 1.87 Billion CNY | 1000.15% |
| 2009 Q1 | 172.68 Million CNY | 111.02% |
| 2009 FY | 2.49 Billion CNY | 261.61% |
| 2008 Q4 | 81.83 Million CNY | -27.45% |
| 2008 Q3 | 112.79 Million CNY | -61.92% |
| 2008 Q2 | 296.21 Million CNY | 48.1% |
| 2008 Q1 | 200.01 Million CNY | -41.55% |
| 2008 FY | 690.85 Million CNY | 10.4% |
| 2007 Q2 | 124.98 Million CNY | 60.92% |
| 2007 FY | 625.78 Million CNY | 141.47% |
| 2007 Q4 | 342.17 Million CNY | 322.66% |
| 2007 Q1 | 77.66 Million CNY | -5.51% |
| 2007 Q3 | 80.95 Million CNY | -35.22% |
| 2006 Q1 | 60.89 Million CNY | 490.69% |
| 2006 Q2 | 63.53 Million CNY | 4.33% |
| 2006 Q3 | 52.52 Million CNY | -17.33% |
| 2006 Q4 | 82.19 Million CNY | 56.47% |
| 2006 FY | 259.15 Million CNY | 62.96% |
| 2005 Q3 | 53.33 Million CNY | -13.75% |
| 2005 Q4 | -15.58 Million CNY | -129.22% |
| 2005 Q1 | 59.44 Million CNY | 34.3% |
| 2005 FY | 159.03 Million CNY | -26.15% |
| 2005 Q2 | 61.83 Million CNY | 4.03% |
| 2004 FY | 215.33 Million CNY | -18.32% |
| 2004 Q4 | 44.26 Million CNY | -9.2% |
| 2004 Q1 | 64.24 Million CNY | 299.15% |
| 2004 Q2 | 58.08 Million CNY | -9.57% |
| 2004 Q3 | 48.74 Million CNY | -16.09% |
| 2003 Q4 | 16.09 Million CNY | -49.84% |
| 2003 Q3 | 32.08 Million CNY | -82.48% |
| 2003 Q2 | 183.17 Million CNY | 467.78% |
| 2003 Q1 | 32.26 Million CNY | -35.52% |
| 2003 FY | 263.61 Million CNY | 79.08% |
| 2002 Q3 | 31.9 Million CNY | -9.2% |
| 2002 Q2 | 35.13 Million CNY | 16.62% |
| 2002 Q1 | 30.13 Million CNY | 0.0% |
| 2002 Q4 | 50.03 Million CNY | 56.82% |
| 2002 FY | 147.21 Million CNY | 8.63% |
| 2001 FY | 135.51 Million CNY | 5.45% |
| 2000 FY | 128.51 Million CNY | 39.45% |
| 1999 FY | 92.15 Million CNY | 44.61% |
| 1998 FY | 63.72 Million CNY | 76.89% |
| 1997 FY | 36.02 Million CNY | 464.89% |
| 1996 FY | 6.37 Million CNY | 6.69% |
| 1995 FY | 5.97 Million CNY | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Pak Fah Yeow International Limited | 105.03 Million HKD | -2171.79% |
| Grand Pharmaceutical Group Limited | 1.87 Billion HKD | -26.929% |
| Extrawell Pharmaceutical Holdings Limited | -162.94 Million HKD | 1564.425% |
| Wai Yuen Tong Medicine Holdings Limited | -15.35 Million HKD | 15639.631% |
| Qianhai Health Holdings Limited | -52.7 Million HKD | 4627.589% |
| Lee's Pharmaceutical Holdings Limited | 16.69 Million HKD | -14190.728% |
| Essex Bio-Technology Limited | 275.25 Million HKD | -766.915% |
| Tongfang Kontafarma Holdings Limited | -28.84 Million HKD | 8373.293% |
| PuraPharm Corporation Limited | -106.08 Million HKD | 2349.475% |
| SSY Group Limited | 1.31 Billion HKD | -80.967% |
| JBM (Healthcare) Limited | 130.46 Million HKD | -1729.075% |
| Jacobson Pharma Corporation Limited | 266.96 Million HKD | -793.84% |
| China Resources Pharmaceutical Group Limited | 3.85 Billion HKD | 38.087% |